CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-27 | Benaim Ely Chief Medical Officer | Exercise or conversion | +1,833 | $47.56 | $87K | 30,887 |
| 2021-05-27 | Benaim Ely Chief Medical Officer | Sale | −1,833 | $200.00 | $367K | 29,054 |
| 2021-05-27 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,833 | 7,332 | ||
| 2021-05-12 | Benaim Ely Chief Medical Officer | Sale | −1,943 | $180.48 | $351K | 29,054 |
| 2021-05-11 | Benaim Ely Chief Medical Officer | Sale | −2,262 | $180.12 | $407K | 30,997 |
| 2021-05-10 | Benaim Ely Chief Medical Officer | Exercise or conversion | +1,833 | $47.56 | $87K | 35,092 |
| 2021-05-10 | Benaim Ely Chief Medical Officer | Sale | −1,833 | $189.65 | $348K | 33,259 |
| 2021-05-10 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,833 | 9,165 | ||
| 2021-05-10 | Weinberg Uri Chief Science Officer | Exercise or conversion | +3,846 | $47.56 | $183K | 37,317 |
| 2021-05-10 | Weinberg Uri Chief Science Officer | Sale | −3,846 | $189.65 | $729K | 33,471 |
| 2021-05-10 | Weinberg Uri Chief Science Officer | Sale | −1,804 | $189.65 | $342K | 31,667 |
| 2021-05-10 | Weinberg Uri Chief Science Officer | Exercise or conversion · Options to Buy Ordinary Shares | −3,846 | 3,845 | ||
| 2021-05-05 | Shah Pritesh Chief Commercial Officer | Sale | −1,290 | $199.67 | $258K | 101,272 |
| 2021-05-05 | LEUNG GABRIEL Director | Exercise or conversion | +1,000 | $31.45 | $31K | 73,045 |
| 2021-05-05 | LEUNG GABRIEL Director | Sale | −1,000 | $199.67 | $200K | 72,045 |
| 2021-05-05 | LEUNG GABRIEL Director | Exercise or conversion · Options to Buy Ordinary Shares | −1,000 | 5,345 | ||
| 2021-05-04 | Shah Pritesh Chief Commercial Officer | Sale | −1,043 | $200.86 | $209K | 102,562 |
| 2021-05-03 | Shah Pritesh Chief Commercial Officer | Exercise or conversion | +2,333 | $204.10 | $476K | 103,605 |
| 2021-05-03 | Shah Pritesh Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −2,333 | 0 | ||
| 2021-04-13 | DOYLE WILLIAM F Executive Chairman | Sale | −1,400 | $191.26 | $268K | 648,993 |
Page 29 of 32 · 638 trades